In the whole cohort, as shown in Fig. 2a, d, patients with MYC overexpressed tumours with low ATM protein or mRNA expression had worse overall breast cancer-specific survival (BCSS) (p < 0.001). The gene discussed is ATM; the disease is neoplasm.